Glenmark’s innovative immune-oncology drug for advanced solid tumors and lymphomas receives FDA acceptance for Phase 1/2 clinical study
Glenmark Pharmaceuticals Ltd.’s subsidiary, Glenmark Specialty SA, has achieved a breakthrough in the fight against advanced solid tumors and lymphomas. The US Food and Drug Administration (FDA) has accepted the company’s Investigational New Drug (IND) application for GRC 54276, an…
Decentralized Clinical Trial to Test Revolutionary Migraine Treatment Device
Mi-Helper, a non-invasive neuromodulation device, is set to revolutionize the treatment of migraines, a condition that affects an estimated one billion people worldwide. Developed by Mi-Helper, Inc., the small device delivers a controlled stream of conditioned air with a nebulized…
Homeopathy treatment protocols are able to reduce thyroid stimulating hormone readings in 52% patients
Homeopathic treatment protocol developed at Dr Kalyan Banerjee’s Clinic are effective in reducing thyroid stimulating hormone readings in 52% hypothyroidism patients within the first follow-up. The results were based on a study of 1200 hypothyroidism patient cases under treatment of…
Elevate Addiction Services Integrates Vivalink Platform for Real-Time Detox Monitoring in Inpatient Treatment
Vivalink, a leading provider of digital healthcare solutions, announces its biometric data platform has been successfully integrated into Elevate Addiction Services’ drug and alcohol in-patient detox treatment program. Vivalink’s Biometrics Data Platform, along with its wearable blood pressure cuff and…
At Apollo Hospitals, a 59-year-old man successfully has robotic surgery to treat his esophageal diverticulum
In a rare case of esophageal diverticulum, a 59 year old man from Yangon, Myanmar underwent a successful robot assisted minimally invasive surgery at Indraprastha Apollo Hospitals (apollohospitaldelhi).The man had been complaining of frequent episodes of vomiting/regurgitation of food after almost every…
Breakthrough Technology Could Lead to One-Time HIV Treatment
TAU researchers demonstrate initial success in neutralizing the virus with a single vaccine Researchers from Tel Aviv University demonstrated the success of a novel technology that may be developed into a one-time vaccine to treat people with HIV and AIDS….
Hospitals in Delhi are fast-filling as patients with breathing problems increase
The impact of deteriorating air quality in the national capital is now visible in the outpatient departments of hospitals in the city. Cases of pollution-related ailments have spiked in the past few weeks, health experts said.Each year, as winter draws…
DCGI approved AstraZeneca’s Lynparza as a monotherapy for adjuvant treatment of patients with high-risk early breast cancer
AstraZeneca India, a leading science-led biopharmaceutical company, today announced that it has received a Drugs Controller General of India (DCGI) approval to market its drug Lynparza (Olaparib) as a monotherapy for the adjuvant treatment of adult patients with BRCA-mutated HER2-…
AstraZeneca partners with Alveofit to scale up the diagnosis and treatment of lung diseases in India.
Under the aegis of its A.Catalyst network, AstraZeneca India announced its partnership with Alveofit, a SaaS-IoT enabled respiratory healthcare platform, to offer IoT enabled handheld spirometers at hospitals across the country. This partnership aims to embed latest technological advancements in…
